BIOVIE INC.
BIVI$10M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaCARSON CITY
Drugs in Pipeline
2
Phase 3 Programs
1
Upcoming Catalysts
1
Next Catalyst
Jun 15, 2026
13wMarket Overview
Stock performance and key metrics
BIVI News
Catalyst Timeline
1 upcoming, 0 past
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
NE3107 | Phase 3 | Parkinsons Disease (PD) | - | - |
Terlipressin acetate continuous infusion | Phase 2 | Cirrhosis | - | - |
Regulatory Approvals
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply